• Skip to main content
  • Skip to primary sidebar

Gold Coast Health & Knowledge Precinct

Transform with us

  • Home
  • About Us
    • Strategic Plan
    • Partners
      • City of Gold Coast
      • Griffith University
      • Gold Coast Health
      • Economic Development Queensland
      • Gold Coast Private Hospital
      • Cohort
      • Southport Sharks
    • Our people
    • Precinct Office
    • Map
    • Contact Us
  • Do Business
    • Investment Incentives
  • Live & Play
    • Australia’s Gold Coast
    • Residential – Smith Collective
    • Lifestyle – Retail and Recreation
  • Work & Study
  • Projects
    • Projects Overview
    • ADaPT
    • Clinical Entrepreneurship Change Agents Program
    • NeuTex Image-guided Surgery and Robotics Training Centre
  • Research
    • Overview
      • Additive Manufacturing
      • Biotechnologies
    • Research Institutes and Centres
    • Precinct experts
    • Research Equipment & Facilities
    • Clinical Trials
    • Health and medical training and conference hub
  • News
    • Latest News
    • Newsletter
    • Media
    • Video Channel
  • 中文
    • English
    • 中文

Filed Under: BUSINESS, HEALTH, TECHNOLOGY Tagged With: Griffith University, healthtech, LuminaX

Griffith University team win top prize at 2023 LuminaX HealthTech Accelerator

After 14 weeks, 20 workshops, 300 hours of mentoring with 30+ mentors and a whole lot of support, 10 gamechanging healthtech startups hit the stage to pitch their businesses in front of more than 200 members of the GCHKP innovation ecosystem at LuminaX 2023 Demo Night.

And from an impressive lineup of commercial concepts to improve patient safety, provide VR treatment for complex mental health conditions, streamline nurse recruitment, revolutionise treatment for children with lower limb deformities and more, a trio of Griffith University researchers were named Startup of the Year for YourTrack, a neurodevelopmental assessment tool for children needing developmental support.

LuminaX Director Dren Xerxa with the YourTrack team: Professor Dianne Shanley, Dr Erinn Hawkins and Dr Wei Lui

Backed by extensive research and with a vision to be powered by AI, YourTrack was developed to track and triage children aged 0-17 years who have developmental concerns. The technology puts neurodevelopmental assessment in the hands of everyday health providers such as GPs and nurses, starting assessment and support earlier, rather than having to wait to rely on specialist paediatricians to assess vulnerable children who are falling behind.

Other clinical assessment tools are largely applicable to young children, but the YourTrack system works for children and adolescents while also providing a greater degree of insight into the extent of a child’s developmental delays.

YourTrack harnesses the power of local health providers so that kids can be ‘diagnosed faster, supported sooner’ and is set to do just that through the commercial acceleration the team achieved through LuminaX.

Professor Dianne Shanley, a clinical psychologist and prominent expert in health service delivery, says the team is excited to have a path towards sharing commercial proceeds from their clinical assessment tool with the community who helped design it.

“The LuminaX journey has been one of the most memorable and engaging learning experiences and we’re so thrilled and surprised to receive the award,” says Professor Shanley.

“The mentoring has helped us to develop a commercial pathway for organisations across the country to access what we’ve co-designed through our research.”

YourTrack Research Manager Dr Wei Liu says LuminaX was invaluable in honing the team’s understanding of customers.

“We reformed our pitch deck, developed our business model and “go to market” strategies, as well as rebranded our logo and website,” says Dr Liu.

“The biggest lesson I learned is to spend time with customers to understand what they want, not what we think they want. Then we present our products as either solving their problems or fulfilling their needs instead of “hard selling” what we have created. 

“We’ve successfully attracted several new customers by using this method.” 

Dr Erinn Hawkins, who co-developed part of the tracking system with a team in Bangladesh, says they now feel confident to work with partners to make YourTrack Developmental Tracking Systems the most trusted developmental assessment system on the market.

“We believe we can now translate our research outcomes into a commercial product that will help us reach and support the more than one million Australian children with developmental vulnerabilities,” she says.

Alignus team aid surgeries during LuminaX
Dr Martina Barzan delivers the Alignus pitch

For the second Griffith University team in the program, biomedical engineer Dr Martina Barzan and clinical researcher Associate Professor Chris Carty of Alignus, LuminaX provided a boost towards the commercial rollout of their world-leading surgery simulation technology to aid orthopaedic surgeries, starting with paediatric patients.

Even during the busy LuminaX program, Dr Barzan worked with surgeons to plan and execute two complex orthopaedic surgeries, taking the total of successful procedures performed with their products to almost 30.

“[In LuminaX] we had access to industry leaders in product development, brand identity and financial modelling, and with the support of the expert LuminaX team, we were able to prepare a compelling pitch that is already attracting investment interest, “says Associate Professor Carty.

“Our next step is to partner with like-minded investors to secure regulatory approval for Alignus products by the end of 2024.”

LuminaX Fan Fave winner optimises nurse recruitment

For nurse Anna Lumb, relocating to Brisbane and searching for the right job sparked her idea to create a dedicated careers marketplace for what she call’s Australia’s almost half-a-million strong “nurseforce”.

Anna Lumb of Nursify won the Fans Fave Award

Struck by the irony of working in Australia’s most sought-after profession but being unable to connect directly with hospitals to find the right role, Nursify was born. One of six female founders to pitch during the slick Demo Night at Miami Marketta, Lumb was judged ‘Fans Fave’.

LuminaX is a 14-week program that validates and commercialises selected early-stage, high-growth activities applying tech or AI solutions to healthcare, medtech and wellness. Developed and delivered by Cohort Innovation Space, it has the support of major partners the Queensland Government (through Economic Development Queensland and Advance Queensland) and City of Gold Coast.

Griffith University, Mater Hospital, the Queensland AI Hub and IntelliHQ are onboard as industry partners.

Cohort has the full event livestream here.


August 2, 2023 By Kathy Kruger

Filed Under: BUSINESS, HEALTH, INVEST, LIVE, PROJECTS

Work commences on premium GCHKP development RDX

(L-R) Debbie McNamara, General Manager EDQ, Craig Mitchell President Northwest Healthcare Properties REIT, Hon Stirling Hinchcliffe, Queensland Minister for Tourism, Innovation and Sport, Dr Hal Rice, Tim Baker, CEO City of Gold Coast

Work has commenced on RDX Lumina, a placemaking Gold Coast Health and Knowledge development by Northwest Healthcare Properties, Australia’s largest healthcare real estate owner.

The Hon. Stirling Hinchliffe, Minister for Tourism, Innovation and Sport yesterday turned sod on the $154m project at a ceremony on the RDX site in the heart of the Precinct’s Lumina commercial district, alongside Northwest President and Regional CEO Craig Mitchell.

RDX is a premium eight-level health and innovation facility fitted for research, biotech, clinical and education functions.

At the ceremony, Mr Hinchcliffe said he expects life sciences work done under RDX’s roof will produce ”innovations that will deliver to the world”.

“We’ll see [RDX] making a massive difference to the way this Precinct delivers on its promise to be a real world-leading cutting edge health and knowledge precinct,” he says. 

Northwest President and Regional CEO Craig Mitchell says the building’s position in the heart of GCHKP will create significant collaboration opportunities for RDX tenants.

“By creating a world-class facility to attract the best people in the industry and encourage further investment in research, development and training, we hope to make a substantial commitment to the broader healthcare industry into the future, in Queensland and beyond.” 

“The GCHKP location represents an added opportunity to collaborate with Griffith University researchers, other clinicians and industry partners.”

Mr Mitchell says RDX will be used for cutting edge life sciences work such as neuroendovascular radiology, interventional cardiology innovation and training, rehabilitation inpatient and outpatient clinical services, human clinical trials, research and virtual care via robotic technologies.

“It’s very important to build the ecosystem where you’ve got the private sector, the public sector, PhD students and researchers—an ecosystem looking at how you take research all the way through to the patient, the whole journey from the lab to bed.” 

After the sod turning, the official party attended the Precinct’s new Neutex Image-Guided Surgical Training and Technologies Centre for a tour conducted by co-founder Dr Hal Rice.

Neutex, a committed tenant of RDX, is working until construction is complete from commercial Precinct space provided by Northwest to deliver world-leading training to specialists from across the Asia Pacific using the latest Philips Image-guided therapy system and technologies. 

The 6-Star Green Star RDX is designed as an all-electric, carbon-neutral building and due for completion mid-2025. 

With Evans Long’s $80m eight-storey development Proxima due for completion 2024, RDX is part of a construction boom in the GCHKP, driven by nearly $250m of private investment. 

June 1, 2023 By Gemma Bull

Filed Under: HEALTH, TECHNOLOGY Tagged With: artificial heart, BiVACOR, Cohort, Griffith Mechanobiology Lab, Griffith University, Medtech

BiVACOR wins new grant for artificial heart development

BiVACOR researchers in the Precinct will focus on a next-generation external device controller as part of their development of a world-first Total Artificial Heart (TAH), supported by a $750k grant from the Australian Government through its Medical Research Future Fund (MRFF) and Targeted Translation Research Accelerator (TTRA) program.

As the company heads towards first-in-human clinical trials within the next two years, the grant, matched by in-kind support bringing approximately AUD$2.2 million in funding towards BiVACOR’s clinical advancement, will help develop a lighter, smaller, more portable external controller to give patients better quality of life at home.

External heart controller development to improve patient comfort

BiVACOR’s novel TAH technology is the first long-term therapy dedicated to patients with severe biventricular heart failure.

The implantable total artificial heart, the size of a human fist, is based on a rotary blood pump and uses magnetic levitation (MAGLEV) technology to enable the double-sided centrifugal impeller to rotate in free-space, minimising blood trauma and eliminating mechanical wear.

Dr Daniel Timms with the BiVACOR TAH

A long labour of love for founder and Chief Technology Officer (CTO) Dr Daniel Timms, the BiVACOR TAH has enjoyed significant Australian government support over its two decades of R&D.

“Heart failure hits close to home for me. It remains a leading cause of death worldwide, and its prevalence is only increasing,” says Dr Timms, who lost his father to the disease.

 “BiVACOR is an Australian-born innovation, and we are extremely grateful for the ongoing support from the Australian government and community.

Without their support, we wouldn’t be where we are today, and this grant gives us a boost in the clinic to drill down into the TAH external controller.”

The TTRA program, a MRFF initiative delivered by MTPConnect, supports new approaches to improve the prevention, dianosis, treatment and management of diabetes and cardiovascular disease complications.

Griffith researchers work on testing the BiVACOR TAH for its blood compatibility

While the implantable device is largely being developed in the US, including through collaboration with the Texas Heart Institute, the latest version heading towards clinical trials has been extensively tested at Griffith University’s Mechanobiology lab, with the aim of understanding and reducing its impact on blood cells.

Across the road at Cohort, where BiVACOR bases its international office, research engineers are focused on the heart’s external controller and its software.

“We want a controller that is as small, lightweight and as ergonomic as possible to maximise portability and comfort,” explains Dr Timms.

“At the same time, it needs to be totally reliable, including its batteries and power system, and we want to create a software interface that enables patients to easily monitor and manage their cardiovascular health, while providing timely and reliable data and alerts to their clinicians when needed.”

During the planned first-in-human trials, patients implanted with the TAH will remain in hospital for monitoring, whilst waiting for a human heart transplant.

“Our goal is to provide the best possible solution for patients facing end-stage heart failure who have run out of options,” says BiVACOR CEO Dr Thomas Vassiliades.

“These funds will give us a clinical advantage as we push on perfecting the external controller for the TAH.”

The BiVACOR TAH builds on the successful transition of Left Ventricular Assist Device (LVAD) technology from volume displacement to durable rotary blood pumps and aims to be the next-generation TAH that sufficiently restores quality of life to patients suffering from severe biventricular heart failure.

The TAH therapy may be initially utilised as a short-term device in a patient awaiting a heart transplant or as a long-term alternative to heart transplantation.

To date, BiVACOR has raised more than AUD$50 million in funding.

February 8, 2023 By Kathy Kruger

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Interim pages omitted …
  • Page 14
  • Go to Next Page »

Primary Sidebar

Recent Posts

  • Healthtech Summit celebrates a future of personalised medicine, AI and hope
  • From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort
  • A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast
  • Clinician Entrepreneurship Program wraps as a big success
  • 2025 International Women’s Day
  • International Women’s Day event 2025
  • Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research
  • INVEST-FEST accelerates founder funding
  • Student innovation incubator set to launch in 2025
  • World-first clinical trial for treating spinal cord injury

Archives

  • June 2025
  • April 2025
  • March 2025
  • February 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • May 2024
  • April 2024
  • January 2024
  • December 2023
  • October 2023
  • September 2023
  • August 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • October 2022
  • August 2022
  • July 2022
  • May 2022
  • March 2022
  • February 2022
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • March 2020
  • February 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018

Subscribe to our newsletter and we’ll update you on all that’s new in our Precinct.

Latest News

Healthtech Summit celebrates a future of personalised medicine, AI and hope image

Healthtech Summit celebrates a future of personalised medicine, AI and hope

Read More >

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort image

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort

Read More >

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast image

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast

Read More >

Clinician Entrepreneurship Program wraps as a big success image

Clinician Entrepreneurship Program wraps as a big success

Read More >

2025 International Women's Day image

2025 International Women's Day

Read More >

International Women's Day event 2025 image

International Women's Day event 2025

Read More >

Before Footer

Search

Asia-Pacific’s emerging health and innovation hub, the 200-hectare Gold Coast Health & Knowledge Precinct (GCHKP) is a unique global business location for high-tech industry development, research collaboration and jobs of the future.

  • Home
  • About Us
  • Precinct Map
  • News
  • Do Business
  • Work & Study
  • Partners
  • Projects
  • Research
  • Contact Us
  • Privacy Policy
  • Sitemap
  • Subscribe
  • Facebook
  • LinkedIn
  • YouTube

© 2025 Gold Coast Health and Knowledge Precinct. All rights reserved.

Designed and Developed by Stead Lane